Literature DB >> 23955455

Frozen section diagnosis: is there discordance between what pathologists say and what surgeons hear?

Somak Roy1, Anil V Parwani, Rajiv Dhir, Samuel A Yousem, Susan M Kelly, Liron Pantanowitz.   

Abstract

OBJECTIVES: Communication in various medical settings is subject to misinterpretation. The frozen section (FS) diagnosis in patient care is dependent on successful communication between pathologists and surgeons. However, very few studies looking at FS errors analyzed postanalytic communication issues.
METHODS: A total of 300 consecutive cases, in which an FS was performed and corresponding surgical note was available, were studied. The FS diagnosis and surgeon's interpretation were recorded for all cases. Discrepancies were classified as major (clinical impact) or minor (no clinical impact).
RESULTS: We found 8 (2.7%) miscommunications, all with only minor clinical impact. These were attributed mainly to the surgeon's misinterpretation of a deferred diagnosis. Also contributing to miscommunication was the pathologist's use of nonspecific terminology such as "favor" or "scattered."
CONCLUSIONS: We found that the rate of miscommunicated FS diagnoses was low at our institution during the period of our study. However, the rate of miscommunication was similar to the much more widely recognized problem of sampling error.

Entities:  

Keywords:  Communication; Defer; Diagnosis; Electronic medical record; Frozen section; Informatics; Intraoperative

Mesh:

Year:  2013        PMID: 23955455     DOI: 10.1309/AJCPHUE5ENZDU4DJ

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  2 in total

1.  Communication skills in diagnostic pathology.

Authors:  Hans-Anton Lehr; Fred T Bosman
Journal:  Virchows Arch       Date:  2015-10-19       Impact factor: 4.064

2.  Evaluation of Role of Intraoperative Cytology Technique in Diagnosis and Management of Cancer.

Authors:  Yashika P Jaiswal; Rasika U Gadkari
Journal:  J Cytol       Date:  2020-06-30       Impact factor: 1.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.